^
BIOMARKER:
HRAS mutation
i
Other names: HRAS, HRAS1, Harvey rat sarcoma viral oncogene homolog
Entrez ID:
Related biomarkers:
HRAS mutation
Thyroid Gland Medullary Carcinoma
cabozantinib capsule
Sensitive
:
A2
HRAS mutation
SCCHN
tipifarnib
Sensitive
:
B
HRAS mutation
Urothelial Cancer
tipifarnib
Sensitive
:
C2
HRAS mutation
AML
venetoclax
Sensitive
:
C3
HRAS mutation
CRC
sorafenib
Sensitive
:
C3
HRAS mutation
CRC
EGFR inhibitor
Sensitive
:
C3
HRAS mutation
AML
venetoclax + ABBV-621
Sensitive
:
C3
HRAS mutation
Salivary Gland Cancer
tipifarnib
Sensitive
:
C3
HRAS mutation
SCCHN
cetuximab
Resistant
:
C3
HRAS mutation
Thyroid Gland Anaplastic Carcinoma
atezolizumab + cobimetinib
Sensitive
:
C3
HRAS mutation
AML
mTOR inhibitor
Resistant
:
D
HRAS mutation
Rhabdomyosarcoma
tipifarnib
Sensitive
:
D
HRAS mutation
Endometrial Cancer
AZ 628
Sensitive
:
D
HRAS mutation
Endometrial Cancer
PD-0325901
Sensitive
:
D
HRAS mutation
Bladder Cancer
FL118
Sensitive
:
D
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our